ClinicaliQ Trial Snapshot
- Magnetic Resonance Imaging Assessment of Multiorgan Health in Obesity — Recruiting • Diabetes / Metabolic • NCT07702825.
- GLP-1 drugs plus lifestyle changes versus lifestyle alone for weight loss and organ health improvement in obese teenagers.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this study is to quantify the body composition and organ fat distribution changes with obesity interventions in adolescents with severe obesity. The main question the investigators aim to answer is if there is improvement in organ health with weight loss intervention. The investigators will be comparing the degree of these changes between children being treated with GLP1 receptor agonists in addition to lifestyle changes and those managed with lifestyle changes alone. Participants will undergo MRI body composition at baseline and after 9 months. Conditions: Childhood Obesity Lead…